On July 15, 2015, Doctor Robert L. Carter of Joplin, Missouri was sentenced to 5 years probation and required to pay more than a million dollars in restitution and fines for purchasing non-FDA approved medications from CanadaDrugs subsidiary Quality Specialty Products (QSP). QSP shipped misbranded and FDA-unapproved drugs to Carter at his practice in Joplin. These misbranded and FDA-unapproved drugs were administered to Carter’s cancer patients and Carter was reimbursed by government and private health insurance programs. Under the terms of his plea agreement, Carter must cease practicing medicine in Missouri during the probation period.
Who: FDA – Office of Criminal Investigations, U.S. Department of Health and Human Services – Office of Inspector General
When: July 15, 2015, 2010-2012.
Where: Joplin, Missouri
How: Investigation by FDA – Office of Criminal Investigations
“ Former Joplin Oncologist Sentenced for Dispensing Foreign, Misbranded Drugs,” FDA July 15, 2015.
“Former Joplin Oncologist Pleads Guilty to Dispensing Foreign, Misbranded Drugs,” DOJ. March 30, 2015